Updated on 21 October 2026
Clinical Trials in Luxembourg and the Grand Region Est, BioBanking for Europe
Director, Translational Medicine Operations Hub, Luxembourg Institute of Health at Luxembourg Institute of Health
1445 Strassen, Luxembourg
About
Accelerating translational medicine from concept to compliant execution
The Luxembourg Institute of Health (LIH) provides an integrated, end-to-end framework for clinical trials and epidemiological research. Combining Good Clinical Practice (GCP) certified clinical operations, centralized project management, and state-of-the-art data and sample workflows, we help biopharma, biotech, and academic partners navigate complex health environments to bring innovative therapies to patients.
Why partner with LIH for clinical trials & research?
-
Integrated single point of contact: Streamlined coordination through a dedicated Clinical Project Management Office (CPMO) handling contracts, timelines, budgets, and cross-functional execution.
-
GCP & regulatory excellence: Fully compliant operations (ICH-GCP, ISO, GDPR) guaranteeing patient rights, data privacy, and seamless ethics/competent authority submissions.
-
Patient-centric infrastructure: Direct access to clinical trial facilities, study nurses, clinical research associates and clinicians, and diverse patient cohorts via the Luxembourg Research Clinic (LRC).
-
End-to-end methodological rigor: Tailored trial designs, adaptive master protocols, and robust sample size calculations designed by expert biostatisticians.
Explore our core capabilities
Proactive governance, portfolio management & single entry point
End-to-end management of complex clinical projects. From initial feasibility and risk assessment to budget control, regulatory setup, and multi-centre monitoring via enterprise tools (Planisware Orchestra).
GCP conform clinical operations, on-site clinical teams & patient access
Full-scale clinical study execution at site level across Luxembourg and the Greater Region. Dedicated Research Nurses, Clinical Research Associates (CRAs), consultation rooms, and recruitment pathways to run Phase I–IV trials and observational cohorts.
Harmonized biological sample workflows & ISO20387-accredited biobanking
Seamless collaboration with the Integrated BioBank of Luxembourg (IBBL). From trial-specific collection kit manufacturing and site logistics to ISO accredited processing, characterization, and long-term multi-temperature storage, ensuring complete sample chain-of-custody.
Competent authority approvals, ethics submissions & compliance
Expert guidance through national and international regulatory landscapes. Complete preparation and submission of dossiers to Ethics Committees and Health Authorities.
Adaptive trial architectures, power calculations & simulation analyses
Rigorously designed clinical research frameworks. Expert clinical trial design (single and parallel arms, adaptive, basket, platform), power calculations, and regulatory-grade Statistical Analysis Plans (SAP).
Data curation, statistical analysis & high-impact output
Seamless transformation of raw clinical data into regulatory-ready datasets and reports, ICH clinical report-grade TLFs, publication-grade figures, and actionable health evidence.
Our Impact in Numbers
-
210+ Clinical studies run / supported
-
60+ Active sponsor collaborations (pharma, biotech, academic)
-
10,350+ Study participants enrolled
-
96 Active managed translational projects
Topic
- Destination 3: HORIZON-HLTH-2027-02-DISEASE-14-two-stage: Clinical trials for advancing innovative interventions for neurodegenerative
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
Hospital-based Translational Research & Clinical Trials Partner
- Partner seeks Consortium/Coordinator
Iacopo Megna
Research Manager - Grant Officer at IRCCS University Hospital SS Antonio e Biagio e C. Arrigo
Alessandria, Italy
Project cooperation
Partnering for AI-Driven Predictive Biomarkers in Chronic Diseases
- Partner seeks Consortium/Coordinator
- Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Inés Martín
European Project Coordinator at Biokeralty Research Institute AIE
Vitoria, Spain
Project cooperation
Serena Gravili
Scientific Project Coordinator at R-Evolution Worldwide
Maglie, Italy